Fetuin A in Hashimoto Thyroiditis - Trial NCT01884649
Access comprehensive clinical trial information for NCT01884649 through Pure Global AI's free database. This phase not specified trial is sponsored by Istanbul Medeniyet University and is currently Completed. The study focuses on Hashimoto Thyroiditis. Target enrollment is 97 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Observational
Sponsor & Location
Istanbul Medeniyet University
Timeline & Enrollment
N/A
May 01, 2012
Oct 01, 2012
Primary Outcome
Comparison of serum fetuin A levels between patients with Hashimoto thyroiditis and healthy subjects
Summary
Fetuin-A levels are reported to be low as a negative acute phase reactant in systemical
 inflammatory situations. Hashimoto thyroiditis is characterized with inflammation. In this
 study, we hypothesised that the serum fetuin A levels could be found to be low due to
 inflammation in patients with Hashimoto thyroiditis
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT01884649
Non-Device Trial